Editor, OncLive®
Caroline Seymour is your initial point of contact for the OncLive® podcast, OncLive On Air™. She joined the company in 2018 as an assistant editor, with expertise in video production and print/digital publication. Email: cseymour@onclive.com
Avelumab Maintenance Proves Equally Effective in Real-World Urothelial Carcinoma Population
March 1st 2024Frontline maintenance therapy with avelumab following platinum-based chemotherapy led to similar outcomes in routine clinical practice and the JAVELIN Bladder 100 trial in metastatic urothelial cancer.
Read More
Neoadjuvant SBRT Plus Cemiplimab Results in Pathologic Responses in Resectable HCC
January 5th 2024Significant tumor necrosis greater than 70% occurred in 3 patients with resectable hepatocellular carcinoma following neoadjuvant treatment with low-dose stereotactic body radiation therapy and cemiplimab-rwlc and adjuvant cemiplimab.
Read More
Futility Analysis Ends Nivolumab and Relatlimab Evaluation in Pretreated MSS mCRC
January 3rd 2024The phase 3 RELATIVITY-123 trial evaluating the fixed-dose combination of nivolumab and relatlimab in patients with microsatellite stable metastatic colorectal cancer will be discontinued due to futility.
Read More